Castle Biosciences Inc (CSTL)
31.53
-0.64
(-1.99%)
USD |
NASDAQ |
Jan 08, 10:02
Castle Biosciences Research and Development Expense (Quarterly): 12.32M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
Delcath Systems Inc | 3.866M |
CytoSorbents Corp | 1.851M |
CytomX Therapeutics Inc | 21.37M |
Spero Therapeutics Inc | 26.86M |
Progyny Inc | -- |